The PRECISE European initiative aims to move cancer research beyond descriptive atlases toward predictive, mechanistically informed models of tumor vulnerability. The PRECISE consortium plans to integrate patient cohorts, disease-relevant model systems, perturbation biology, multimodal profiling and artificial intelligence-driven inference to learn generalizable and predictive rules that govern genetic dependencies and synthetic lethality.